For more than 125 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals — including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases — as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.msd.com and connect with us on Twitter, LinkedIn and YouTube.
| Website | http://www.msdchina.com.cn/ |
| Revenue | $2.2 billion |
| Employees | 1,680 (115 on RocketReach) |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Vaccines, Biotechnology, Healthcare, Prescription Drugs, Drug Discovery, Clinical Trials, Global Health, Pharmaceutical Research, Drug Development, Life Sciences, Biopharma, Medical Research, Health Innovation, Therapeutic Solutions, Innovative Medicines, Disease Treatment, Prevention, Patient Care |
| Competitors | AstraZeneca, Merck Group, Johnson & Johnson China, 阿斯利康制药有限公司, Shanghai Novartis Trading Limited, 中美上海施贵宝制药有限公司, Bayer Limited, 广州数控设备有限公司, 艾伯维医药贸易(上海)有限公司, 上海罗氏有限公司 +38 more (view full list) |
Looking for a particular MSD China employee's phone or email?
The MSD China annual revenue was $2.2 billion in 2026.
Jack Shih is the Executive Director and VP, Diabetes Business Unit and Retail of MSD China.
115 people are employed at MSD China.